These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19535632)

  • 1. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.
    Dou H; Grotepas CB; McMillan JM; Destache CJ; Chaubal M; Werling J; Kipp J; Rabinow B; Gendelman HE
    J Immunol; 2009 Jul; 183(1):661-9. PubMed ID: 19535632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.
    Dou H; Destache CJ; Morehead JR; Mosley RL; Boska MD; Kingsley J; Gorantla S; Poluektova L; Nelson JA; Chaubal M; Werling J; Kipp J; Rabinow BE; Gendelman HE
    Blood; 2006 Oct; 108(8):2827-35. PubMed ID: 16809617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery.
    Gorantla S; Dou H; Boska M; Destache CJ; Nelson J; Poluektova L; Rabinow BE; Gendelman HE; Mosley RL
    J Leukoc Biol; 2006 Nov; 80(5):1165-74. PubMed ID: 16908517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages.
    Dou H; Morehead J; Destache CJ; Kingsley JD; Shlyakhtenko L; Zhou Y; Chaubal M; Werling J; Kipp J; Rabinow BE; Gendelman HE
    Virology; 2007 Feb; 358(1):148-58. PubMed ID: 16997345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
    Kanmogne GD; Singh S; Roy U; Liu X; McMillan J; Gorantla S; Balkundi S; Smith N; Alnouti Y; Gautam N; Zhou Y; Poluektova L; Kabanov A; Bronich T; Gendelman HE
    Int J Nanomedicine; 2012; 7():2373-88. PubMed ID: 22661891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model.
    Haile WB; Gavegnano C; Tao S; Jiang Y; Schinazi RF; Tyor WR
    Neurobiol Dis; 2016 Aug; 92(Pt B):137-43. PubMed ID: 26851503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis.
    Limoges J; Poluektova L; Ratanasuwan W; Rasmussen J; Zelivyanskaya M; McClernon DR; Lanier ER; Gendelman HE; Persidsky Y
    Virology; 2001 Mar; 281(1):21-34. PubMed ID: 11222092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis.
    Poluektova LY; Munn DH; Persidsky Y; Gendelman HE
    J Immunol; 2002 Apr; 168(8):3941-9. PubMed ID: 11937550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis.
    Persidsky Y; Buttini M; Limoges J; Bock P; Gendelman HE
    J Neurovirol; 1997 Dec; 3(6):401-16. PubMed ID: 9475112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.
    Nowacek AS; Miller RL; McMillan J; Kanmogne G; Kanmogne M; Mosley RL; Ma Z; Graham S; Chaubal M; Werling J; Rabinow B; Dou H; Gendelman HE
    Nanomedicine (Lond); 2009 Dec; 4(8):903-17. PubMed ID: 19958227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis.
    Spitzenberger TJ; Heilman D; Diekmann C; Batrakova EV; Kabanov AV; Gendelman HE; Elmquist WF; Persidsky Y
    J Cereb Blood Flow Metab; 2007 May; 27(5):1033-42. PubMed ID: 17063148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of weekly HIV drug delivery to enhance drug localization in lymphoid tissues based on pharmacokinetic models of lipid-associated indinavir.
    Snedecor SJ; Sullivan SM; Ho RJ
    Pharm Res; 2006 Aug; 23(8):1750-5. PubMed ID: 16832614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.
    Nowacek AS; Balkundi S; McMillan J; Roy U; Martinez-Skinner A; Mosley RL; Kanmogne G; Kabanov AV; Bronich T; Gendelman HE
    J Control Release; 2011 Mar; 150(2):204-11. PubMed ID: 21108978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement.
    Karami Z; Saghatchi Zanjani MR; Rezaee S; Rostamizadeh K; Hamidi M
    Drug Dev Ind Pharm; 2019 May; 45(5):736-744. PubMed ID: 30640551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of indinavir and nelfinavir in human immunodeficiency virus type 1-infected adults: safety, pharmacokinetics, and antiretroviral activity.
    Riddler SA; Havlir D; Squires KE; Kerr B; Lewis RH; Yeh K; Wynne LH; Zhong L; Peng Y; Deutsch P; Saah A
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3877-82. PubMed ID: 12435691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
    Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
    Viruses; 2020 May; 12(5):. PubMed ID: 32443728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis.
    Potula R; Haorah J; Knipe B; Leibhart J; Chrastil J; Heilman D; Dou H; Reddy R; Ghorpade A; Persidsky Y
    Am J Pathol; 2006 Apr; 168(4):1335-44. PubMed ID: 16565506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis.
    Dou H; Ellison B; Bradley J; Kasiyanov A; Poluektova LY; Xiong H; Maggirwar S; Dewhurst S; Gelbard HA; Gendelman HE
    J Neurosci; 2005 Sep; 25(37):8375-85. PubMed ID: 16162919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.
    Nowacek AS; McMillan J; Miller R; Anderson A; Rabinow B; Gendelman HE
    J Neuroimmune Pharmacol; 2010 Dec; 5(4):592-601. PubMed ID: 20237859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.